血液制品臨床應(yīng)用指導(dǎo)原則(征求意見稿)

1、1血液制品臨床應(yīng)用指導(dǎo)原則血液制品臨床應(yīng)用指導(dǎo)原則（征求意（征求意見稿）稿）目錄前言...................................................................................5第一章第一章血液制品臨床應(yīng)用基本原則血液制品臨床應(yīng)用基本原則.........................................................6一、嚴(yán)格掌握

2、適應(yīng)證和應(yīng)用指征...........................................................6二、血液制品的選擇.....................................................................6三、避免輸注血液制品的不良反應(yīng).........................................................6

3、第二章第二章血液制品臨床應(yīng)用管理血液制品臨床應(yīng)用管理.............................................................7一、管理要求...........................................................................7（一）全血及血液成分的臨床應(yīng)用管理要求...............................

4、................71.來(lái)源管理.........................................................................72.程序管理.........................................................................73.人員管理.....................................

5、....................................74.臨床用血分級(jí)管理.................................................................8（二）血漿源醫(yī)藥產(chǎn)品的管理要求.......................................................81.來(lái)源的管理.............................

6、..........................................82.應(yīng)用的管理.......................................................................8二、落實(shí)與督查.........................................................................9第三章第三章各類血液制品使用的適應(yīng)

7、證和注意事項(xiàng)各類血液制品使用的適應(yīng)證和注意事項(xiàng)..............................................10一、全血..............................................................................10二、紅細(xì)胞............................................................

8、................103（一）缺鐵性貧血....................................................................38（二）溶血性貧血....................................................................39自身免疫性溶血性貧血...................................

9、...........................39EVANS綜合征.......................................................................41珠蛋白生成障礙性貧血（地中海貧血）................................................42葡萄糖6磷酸脫氫酶缺乏癥...............................

10、..........................44陣發(fā)性睡眠性血紅蛋白尿癥..........................................................45（三）慢性病貧血....................................................................46（四）再生障礙性貧血................................

11、................................48重型再障..........................................................................48輕型再障..........................................................................50（五）骨髓增生異常綜合征..............

12、..............................................51（六）急性白血病....................................................................54（七）淋巴瘤........................................................................57（八）多發(fā)性骨髓瘤.....

13、.............................................................58（九）原發(fā)性免疫性血小板減少癥......................................................59（十）血栓性血小板減少性紫癜........................................................61（十一）血友病.......

14、...............................................................62血友病A...........................................................................62血友病B......................................................................

15、.....65血管性血友病......................................................................66（十二）彌散性血管內(nèi)凝血............................................................66（十三）造血干細(xì)胞移植..................................................